Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)”

256 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 256 results

Very early researchStudy completedNCT01184885
What this trial is testing

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Who this might be right for
Lymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 7
Testing effectiveness (Phase 2)Study completedNCT02523976
What this trial is testing

Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute,Leukemia, Lymphoid
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06773936
What this trial is testing

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaCD19+ Acute Leukemia
SWOG Cancer Research Network 55
Not applicableUnknownNCT01193933
What this trial is testing

Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment

Who this might be right for
Ph-negative Adult Acute Lymphoblastic Leukemia
National Research Center for Hematology, Russia 321
Not applicableLooking for participantsNCT06481228
What this trial is testing

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

Who this might be right for
Philadelphia Positive Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, Adult
Institute of Hematology & Blood Diseases Hospital, China 82
Testing effectiveness (Phase 2)Study completedNCT01523782
What this trial is testing

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
ERYtech Pharma 30
Testing effectiveness (Phase 2)Study completedNCT01445080
What this trial is testing

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Who this might be right for
Blastic PhaseChildhood Acute Promyelocytic Leukemia With PML-RARAChildhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive+7 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT03480438
What this trial is testing

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

Who this might be right for
B-Precursor ALL
Goethe University 52
Large-scale testing (Phase 3)UnknownNCT02611492
What this trial is testing

A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults

Who this might be right for
Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia
Assistance Publique - Hôpitaux de Paris 265
Testing effectiveness (Phase 2)Active Not RecruitingNCT02629692
What this trial is testing

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Who this might be right for
Healthy (For Part A)Chronic Myeloid Leukemia (for Part B and C)
Sun Pharma Advanced Research Company Limited 122
Testing effectiveness (Phase 2)Looking for participantsNCT06918431
What this trial is testing

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeLymphoblastic Lymphoma
City of Hope Medical Center 53
Testing effectiveness (Phase 2)Ended earlyNCT00405054
What this trial is testing

A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)

Who this might be right for
Leukemia
Merck Sharp & Dohme LLC 52
Early research (Phase 1)Study completedNCT02185781
What this trial is testing

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)
Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Early research (Phase 1)UnknownNCT05523661
What this trial is testing

Dasatinib Plus Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for Elderly Ph-positive ALL Patients

Who this might be right for
Ph Positive ALLCAR-T CellDasatinib
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 15
Post-approval studies (Phase 4)UnknownNCT01358201
What this trial is testing

PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years

Who this might be right for
Acute Lymphoblastic Leukemia
PETHEMA Foundation 100
Early research (Phase 1)Looking for participantsNCT05157971
What this trial is testing

Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaPh-Like Acute Lymphoblastic Leukemia
City of Hope Medical Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT01371630
What this trial is testing

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeBurkitt-Like Lymphoma With 11q Aberration+6 more
M.D. Anderson Cancer Center 276
Testing effectiveness (Phase 2)Ended earlyNCT00905398
What this trial is testing

Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemia
Rony Schaffel 8
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Looking for participantsNCT06393985
What this trial is testing

Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University 30
Load More Results